Keros Therapeutics saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Keros Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Keros Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 25% filings and 50% grants. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), United States(US), and South Korea(KR) patent Office are among the top ten patent offices where Keros Therapeutics is filings its patents. Among the top granted patent authorities, Keros Therapeutics has 50% of its grants in European Patent Office(EPO) and 50% in Australia(AU).
Regeneron Pharmaceuticals and Roche could be the strongest competitors for Keros Therapeutics
Patents related to climate change and rare diseases lead Keros Therapeutics's portfolio
Keros Therapeutics has the highest number of patents in climate change followed by, rare diseases. For climate change, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Fibrosis related patents lead Keros Therapeutics portfolio followed by pulmonary hypertension, and neutropenia
Keros Therapeutics has highest number of patents in fibrosis followed by pulmonary hypertension, neutropenia, obesity, and atrophy.
For comprehensive analysis of Keros Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
